Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response

被引:36
作者
Nieminen, T [1 ]
Käyhty, H [1 ]
Virolainen, A [1 ]
Eskola, J [1 ]
机构
[1] Natl Publ Hlth Inst, Helsinki, Finland
关键词
pneumococcal vaccines; mucosal response; antibody secreting cells;
D O I
10.1016/S0264-410X(97)00162-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study assessed the mucosal immune response in healthy adult volunteers immunized parenterally with either pneumococcal polysaccharide (N = 8) or pneumococcal polysaccharide-protein conjugate (N = 10) vaccine with an aim to evaluate the relevance of antibody secreting cell (ASC) response after parenteral vaccination. An ASC response to the four types of capsular polysaccharide tested was observed in all vaccinees 7-9 days after immunization IgA was the predominant class in the ASC response, and IgG the next common, with very few IgM ASCs. The IgA/IgG ratio in the ASC response was higher after immunization with the polysaccharide than the conjugate vaccine. Antibodies of the IgA class were frequently seen in the saliva already before immunization; especially to serotypes 14 and 19F. A twofold increase of the type specific secretory IgA antibodies in saliva was found in eight of the 16 instances in which the specific IgA ASC response was > 100 ASC per 10(6) cells and in only one of the 52 instances with fewer ASCs. We conclude that the ASC response in the peripheral blood is a useful parameter of the antibody response To pneumococcal vaccines and a good indicator of a secretory IgA response in the saliva. (C) 1997 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 33 条
  • [21] MAKELA PH, 1989, J PEDIAT INFECT DI S, V8, P79
  • [22] MCDERMOTT MR, 1979, J IMMUNOL, V122, P1892
  • [23] CARRIAGE OF HAEMOPHILUS-INFLUENZAE TYPE-B IN CHILDREN AFTER WIDESPREAD VACCINATION WITH CONJUGATE HAEMOPHILUS-INFLUENZAE TYPE-B VACCINES
    MOHLEBOETANI, JC
    AJELLO, G
    BRENEMAN, E
    DEAVER, KA
    HARVEY, C
    PLIKAYTIS, BD
    FARLEY, MM
    STEPHENS, DS
    WENGER, JD
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (07) : 589 - 593
  • [24] DECREASED HAEMOPHILUS COLONIZATION IN CHILDREN VACCINATED WITH HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINE
    MURPHY, TV
    PASTOR, P
    MEDLEY, F
    OSTERHOLM, MT
    GRANOFF, DM
    [J]. JOURNAL OF PEDIATRICS, 1993, 122 (04) : 517 - 523
  • [25] Antibody-secreting cells and their relation to humoral antibodies in serum and in nasopharyngeal aspirates in children with pneumococcal acute otitis media
    Nieminen, T
    Virolainen, A
    Kayhty, H
    Jero, J
    Karma, P
    Leinonen, M
    Eskola, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) : 136 - 141
  • [26] Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults
    Powers, DC
    Anderson, EL
    Lottenbach, K
    Mink, CM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) : 1014 - 1018
  • [27] ASSIGNMENT OF WEIGHT-BASED ANTIBODY UNITS TO A HUMAN ANTIPNEUMOCOCCAL STANDARD REFERENCE SERUM, LOT 89-S
    QUATAERT, SA
    KIRCH, CS
    WIEDL, LJQ
    PHIPPS, DC
    STROHMEYER, S
    CIMINO, CO
    SKUSE, J
    MADORE, DV
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (05) : 590 - 597
  • [28] COMPARATIVE IMMUNOGENICITY OF GROUP-6 PNEUMOCOCCAL TYPE-6A(6) AND TYPE-6B(26) CAPSULAR POLYSACCHARIDES
    ROBBINS, JB
    LEE, CJ
    RASTOGI, SC
    SCHIFFMAN, G
    HENRICHSEN, J
    [J]. INFECTION AND IMMUNITY, 1979, 26 (03) : 1116 - 1122
  • [29] CONSIDERATIONS FOR FORMULATING THE 2ND-GENERATION PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE WITH EMPHASIS ON THE CROSS-REACTIVE TYPES WITHIN GROUPS
    ROBBINS, JB
    AUSTRIAN, R
    LEE, CJ
    RASTOGI, SC
    SCHIFFMAN, G
    HENRICHSEN, J
    MAKELA, PH
    BROOME, CV
    FACKLAM, RR
    TIESJEMA, RH
    PARKE, JC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (06) : 1136 - 1159
  • [30] STROBER W, 1985, ADV HOST DEFENSE MEC, V4, P1